Nianqiu Liu on Muck Rack

Nianqiu Liu

As seen in: Nature, PLOS ONE, Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nianqiu

Contact Nianqiu, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Everolimus destabilizes thymidylate synthase via suppressing its O-GlcNAcylation and sensitizes HER2-negative breast cancer to fluorouracil

|
By Xiao-Ting Jiang, Shaoyi Wang, Linghan Wang, Zijie Cai, Jingru Wang, Mengdi Zhu, Nianqiu Liu, Wang Yang, Yujie Liu, Liang Jin, Yudong Li, Shunying Li, Qianfeng Shi, Jinna Lin, Keyang Qian, Qi Wang, Xin Yang, Yingyan Chen, Yinxia Wu, Qiang Liu, Huipei Gan, Zhuangqiu Yang
| Nature Verified
Abstract 5-Fluorouracil (5-FU) and its prodrugs are widely used drugs for chemotherapy in various cancers. However, their effectiveness in breast cancer is limited. mTORC1 pathway, as a known mediator of therapy resistance in breast cancer, presents a compelling target for combination approaches.
Open in Who Shared Issue with article?

Correction: Repurposing cephalosporins as excellent anticancer agents and chemosensitizers for inflammation-driven cancer therapy

|
By Nianqiu Liu, Jiefu Tang, Ruimei Dong, Juan Guo, Zhuang Luo, Qian Yao, Zhuoxuan Liang, Yuntao Yang, Jie Zhou, Wenlin Chen, Hongmin Liang, Xiaoqiong He, Weihan Cao, Menying Gu
| Nature Verified
Correction to: Scientific Reports https://doi.org/10.1038/s41598-025-25287-8, published online 21 November 2025 The original version of this Article contained an error in the name of author Hongmin Liang which was incorrectly given as Hongming Liang. The original Article has been corrected.
Open in Who Shared Issue with article?

Synchronous primary breast invasive carcinoma and breast metastasis from high-grade serous ovarian carcinoma: a case report and literature review

|
By Nianqiu Liu, Fuhong Gong, Jiayi Chen, Chenxi Wang, Yilin Chen, Fei Ge, Wenlin Chen, Jingge Miao, Mengping Lin
| Frontiers
Abstract Background: Breast metastasis from high-grade serous ovarian carcinoma is rare, and its coexistence with a synchronous primary breast carcinoma is exceptionally uncommon. Distinguishing metastatic ovarian carcinoma from primary breast carcinoma is clinically important because treatment strategies and prognosis differ substantially.
Open in Who Shared Issue with article?
See all 5 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified